Published in Surg Endosc on July 12, 2016
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser (1995) 57.68
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Obesity and diabetes in the developing world--a growing challenge. N Engl J Med (2007) 10.54
Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology (2006) 10.05
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc (1980) 8.36
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology (2010) 8.05
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology (1990) 6.53
Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology (2001) 5.07
Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology (2003) 4.95
The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg (2006) 2.93
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology (2004) 2.77
Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) (2009) 2.70
State-specific prevalence of obesity among adults--United States, 2005. MMWR Morb Mortal Wkly Rep (2006) 2.58
Non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2002) 2.32
Obesity in Saudi Arabia. Saudi Med J (2005) 2.30
Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia (2009) 2.03
Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology (2006) 1.75
Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg (2005) 1.70
Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology (2009) 1.67
Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol (2007) 1.39
Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut (2010) 1.30
Adipocytokines and liver disease. J Gastroenterol (2008) 1.25
NASH: A global health problem. Hepatol Res (2011) 1.24
Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg (2003) 1.24
Regression of hepatic steatosis in morbidly obese persons after gastric bypass. Am J Clin Pathol (1995) 1.10
Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obes Res (2005) 1.08
National trends in utilization and outcomes of bariatric surgery. Surg Endosc (2005) 1.08
Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics. Int J Clin Exp Med (2010) 1.08
Sustained weight loss in obese subjects has benefits that are independent of attained weight. Obes Res (2004) 1.03
Characteristics of patients undergoing bariatric surgery in Canada. Obes Res (2005) 1.03
Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Obes Surg (2002) 0.98
Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery. J Gastrointest Surg (2004) 0.98
Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. Obes Surg (2003) 0.90
Epidemiological, clinical, and biochemical characteristics of Saudi patients with nonalcoholic fatty liver disease: a hospital-based study. Ann Saudi Med (2012) 0.87
Prevalence of non-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass. Obes Surg (2003) 0.87
Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS One (2013) 0.87
Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) -- preliminary findings. Obes Surg (2005) 0.85
Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis. Clin Liver Dis (2007) 0.81
Short-term liver function after biliopancreatic diversion. Obes Surg (2003) 0.80
Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months. Obes Surg (2005) 0.80
Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery. Saudi J Anaesth (2017) 0.75